Osenvelt
NDC 72606-038, denosumab-bmwo, injection, from CELLTRION USA, Inc..
- Product NDC
- 72606-038
- Status
- Listed
- Labeler
- CELLTRION USA, Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761404
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72606-038 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DENOSUMAB120 mg/1.7mL
Pharmacologic classes
RANK Ligand Blocking Activity [MoA]; RANK Ligand Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72606-038-01 | 72606003801 | 1 VIAL, SINGLE-USE in 1 CARTON (72606-038-01) / 1.7 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c5a5d750-80be-49cd-b4a6-c8a815956059Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=72606-038
Use it
Look up 72606-038 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72606-038 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72606-038. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.